Tuesday, August 08, 2006
Drug Wars Update
Medco Health Solutions, another one of the big three prescription benefit managers, has announced that it will begin dispensing Apotex's generic version of the anti-blood clotting drug Plavix tomorrow. According to Marketwatch.com, "Medco members account for 24% of Plavix's U.S. market share, and more than half of Medco's Plavix prescriptions are filled through the company's mail-order pharmacies." Apotex evidently is trying to flood the market with the generic drug before the brand name manufacturers can get to court under an earlier settlement agreement.